As a complement to our wider contract manufacturing capabilities around the world, our expertise in Cork includes tablets, mini-tablets and capsule formulations. The Cork facility is accredited by regulatory bodies, including the FDA and Irish Medicines Board (IMB) and it is licensed to distribute to the United States, Canada, Europe and much of the rest of the world.
Founded in 2001, this 13 acre drug contract manufacturing site houses a highly automated drug product manufacturing plant along with pilot scale production to support clinical drug production needs.
AbbVie’s Cork, Ireland cGMP manufacturing expertise:
- Tablet Coating
- Spray Coating (Glatt)
- Massing Granulation (High Shear)
- Massing Granulation (Low Shear)
- Spray Granulation (Fluid Bed)
- Bi-Layer Tablets
- Drying Granulation (Fluid Bed)
- Particle Coating
- Direct Compression (Dry Blend)